1Bischoff TR,Tallent S,Adera T,et al.Epidemiology of nosocomial candidemia:a six -year national perspective[C].In:43^rd ICAAC abstracts.American Society for Microbiology,2003:348. 被引量：1
2Almyroudis N,Jaffe D,Sepkowitz KA,et al.Risk factors for late invasive aspergillosis after allogeneic stem cell transplantation[C].In:43rd ICAAC abstracts.American Society for Microbiology,2003:457. 被引量：1
3Pappas PG,Morgan J,Hajjeh RA.Transplant Associated Infection Surveillance Network (TRANSNET) (2003) Prospective surveillance for invasive fungal infections (IFIs) in hematopoietic stem cell (HSCTs) and solid organ transplant recipients (SOTs) in the United States[C].In:43rd ICAAC abstracts.American Society for Microbiology,2003:458. 被引量：1
7Winston DJ,Maziarz RT,Chandrasekar PH,et al.Long-term antifungal prophylaxis in allogeneic bone marrow transplant patients:a multicenter,randomized trial of intravenous/oral itraconazole versus intravenous/oral fluconazole[J].Ann Inten Med,2003,138:705-713. 被引量：1
8Mattiuzzi GN,Kantariian H,Alvarado G,et al.Intravenous itraconazole vs caspofungin prophylaxis in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy[C].In:43rd ICAAC abstracts.American Society for Microbiology,2003:451. 被引量：1
9Stute N,Kratochwille A,Zabelina T,et al.Caspofungin is highly effective as secondary prophylaxis in allogeneic stem cell transplantation in patients with prior systemic or invasive fungal infections[C].In:Proceedings45th ASH,2003:3636. 被引量：1
10Cornely OA,Bethe U,Cesaro S,et al.Detection of predictor variables for breakthrough invasive fungal infection during secondary prophylaxis:results from a European registry[C].In:43rd ICAAC Abstracts.American Society for Microbiology,2003:456. 被引量：1
